Catherine R. Oliver-garcia

Array ( [id] => 641633 [patent_doc_number] => 07122332 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-17 [patent_title] => 'Modulators of leukocyte activation, compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 10/039761 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 47 [patent_no_of_words] => 32843 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/122/07122332.pdf [firstpage_image] =>[orig_patent_app_number] => 10039761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711793 [patent_doc_number] => 20030171542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Mammalian secretory peptide - 9' [patent_app_type] => new [patent_app_number] => 10/082502 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16621 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171542.pdf [firstpage_image] =>[orig_patent_app_number] => 10082502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6621988 [patent_doc_number] => 20020065224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-30 [patent_title] => 'Caveolin-1 gene and polypeptide encoded thereby and methods of use thereof' [patent_app_type] => new [patent_app_number] => 09/976773 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20058 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20020065224.pdf [firstpage_image] =>[orig_patent_app_number] => 09976773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7628082 [patent_doc_number] => 06806354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-10-19 [patent_title] => 'Methods and compositions for inducing autoimmunity in the treatment of cancers' [patent_app_type] => B2 [patent_app_number] => 09/974753 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 17052 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/806/06806354.pdf [firstpage_image] =>[orig_patent_app_number] => 09974753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745064 [patent_doc_number] => 20030022247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Substance which inhibits binding of information transfer molecule for 1175-tyrosine phosphorylated KDR/FLK-1 and usages of the same' [patent_app_type] => new [patent_app_number] => 09/969037 [patent_app_country] => US [patent_app_date] => 2001-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17774 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022247.pdf [firstpage_image] =>[orig_patent_app_number] => 09969037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7295831 [patent_doc_number] => 20040214155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Methods and compositions for screening for modulators of IgE synthesis, secretion and switch rearrangement' [patent_app_type] => new [patent_app_number] => 09/963247 [patent_app_country] => US [patent_app_date] => 2001-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 20399 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214155.pdf [firstpage_image] =>[orig_patent_app_number] => 09963247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1102190 [patent_doc_number] => 06815532 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-09 [patent_title] => 'ATR-2 cell cycle checkpoint' [patent_app_type] => B2 [patent_app_number] => 09/957837 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24525 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/815/06815532.pdf [firstpage_image] =>[orig_patent_app_number] => 09957837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6278493 [patent_doc_number] => 20020107196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Method for inducing chemotaxis in endothelial cells by administering stromal cell derived factor-1alpha' [patent_app_type] => new [patent_app_number] => 09/953717 [patent_app_country] => US [patent_app_date] => 2001-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14821 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20020107196.pdf [firstpage_image] =>[orig_patent_app_number] => 09953717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6278486 [patent_doc_number] => 20020107195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Method for inducing chemotaxis in endothelial cells by administering stromal cell derived factor-1alpha' [patent_app_type] => new [patent_app_number] => 09/953692 [patent_app_country] => US [patent_app_date] => 2001-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14803 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20020107195.pdf [firstpage_image] =>[orig_patent_app_number] => 09953692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6015030 [patent_doc_number] => 20020102271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Target of RNAIII activating protein (TRAP)' [patent_app_type] => new [patent_app_number] => 09/953780 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11672 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102271.pdf [firstpage_image] =>[orig_patent_app_number] => 09953780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828602 [patent_doc_number] => 20020068353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Compositions and method for determining the presence of human PTTG peptide in a sample' [patent_app_type] => new [patent_app_number] => 09/949476 [patent_app_country] => US [patent_app_date] => 2001-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15537 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068353.pdf [firstpage_image] =>[orig_patent_app_number] => 09949476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847359 [patent_doc_number] => 20030166526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Nucleic acid and corresponding protein named 158P1H4 useful in the treatment and detection of bladder and other cancers' [patent_app_type] => new [patent_app_number] => 09/935384 [patent_app_country] => US [patent_app_date] => 2001-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 77655 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166526.pdf [firstpage_image] =>[orig_patent_app_number] => 09935384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6692226 [patent_doc_number] => 20030039658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'MCEF, a novel transcription factor' [patent_app_type] => new [patent_app_number] => 09/932257 [patent_app_country] => US [patent_app_date] => 2001-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20535 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20030039658.pdf [firstpage_image] =>[orig_patent_app_number] => 09932257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7620170 [patent_doc_number] => 06943011 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-13 [patent_title] => 'Localization and characterization of the Wilms\' tumor gene' [patent_app_type] => utility [patent_app_number] => 09/929315 [patent_app_country] => US [patent_app_date] => 2001-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 14248 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/943/06943011.pdf [firstpage_image] =>[orig_patent_app_number] => 09929315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6687948 [patent_doc_number] => 20030031673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Treatment and diagnosis of cancer' [patent_app_type] => new [patent_app_number] => 09/929546 [patent_app_country] => US [patent_app_date] => 2001-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13556 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20030031673.pdf [firstpage_image] =>[orig_patent_app_number] => 09929546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 752519 [patent_doc_number] => 07018419 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-28 [patent_title] => 'Microporous encapsulated endocrine cell disks, biconcave disks and multidimpled chambers for hormonal replacement' [patent_app_type] => utility [patent_app_number] => 09/928392 [patent_app_country] => US [patent_app_date] => 2001-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 9 [patent_no_of_words] => 2612 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/018/07018419.pdf [firstpage_image] =>[orig_patent_app_number] => 09928392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6157543 [patent_doc_number] => 20020146712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Tumor suppressor' [patent_app_type] => new [patent_app_number] => 09/924654 [patent_app_country] => US [patent_app_date] => 2001-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 19431 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146712.pdf [firstpage_image] =>[orig_patent_app_number] => 09924654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 710262 [patent_doc_number] => 07056690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Detection of dysplastic or neoplastic cells using anti-MCM2 antibodies' [patent_app_type] => utility [patent_app_number] => 09/922652 [patent_app_country] => US [patent_app_date] => 2001-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15805 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056690.pdf [firstpage_image] =>[orig_patent_app_number] => 09922652 [rel_patent_id] =>[rel_patent_doc_number] =>)